ISO 15378 Explained

An independent overview from DQS, an accredited certification body.

ISO 15378 is the international management system standard for manufacturers of primary packaging materials for medicinal products. It specifies requirements for a quality management system that supports the consistent design, manufacture, and supply of materials such as glass containers, rubber closures, plastic bottles, aluminium tubes, films, foils, and laminate containers used in direct contact with medicinal products. The standard integrates the full requirements of ISO 9001 with the relevant principles of Good Manufacturing Practice (GMP) for pharmaceutical packaging.

The standard is relevant to organizations across the pharmaceutical packaging supply chain — from manufacturers of bulk packaging components to converters and finishers — as well as to their pharmaceutical customers, regulators, and supply-chain partners who expect documented assurance that primary packaging materials are produced under controlled, GMP-aligned conditions.

The current base standard is ISO 15378:2017, It is supplemented by ISO 15378:2017/Amd 1:2024 on climate action changes, which aligns with ISO 9001:2015 and the Harmonized Structure. With ISO 9001 currently undergoing revision (ISO/FDIS 9001 in the publication pipeline), a future revision of ISO 15378 is expected in due course to follow the revised version of ISO 9001.

What is ISO 15378, from a certification body’s perspective?

From a certification body’s perspective, ISO 15378 is the certifiable, sector-specific application of ISO 9001 for primary packaging materials for medicinal products. An accredited certification body assesses an organization’s quality management system against the standard’s requirements through an independent, two-stage audit and, on conformity, issues a certificate that is then maintained by periodic surveillance.

ISO 15378 follows the Harmonized Structure of ISO 9001 and integrates GMP-derived requirements specific to pharmaceutical packaging — change and deviation control, contamination prevention, process and equipment validation, environmental monitoring, and traceability of packaging materials to the medicinal product context. Third-party certification provides independent evidence of conformance and serves as a recognized reference for pharmaceutical customers, regulators, and supply-chain partners who rely on documented quality assurance from their packaging suppliers as part of their own supplier qualification programmes.

DQS assesses and certifies conformity. It does not design or implement the customer’s ISO 15378 management system.. That independence is what gives a certificate its value: the organization builds and runs the system, and an accredited third party verifies it against the standard.

Key Facts about ISO 15378 at a Glance

Context and Drivers for ISO 15378

GMP Expectations in the Pharmaceutical Supply Chain

Primary packaging materials are a critical input in pharmaceutical manufacturing because they are intended to come into direct contact with medicinal products. Pharmaceutical manufacturers therefore expect their suppliers to operate controlled, documented and risk-based quality management systems.

ISO 15378 provides a structured framework for manufacturers and suppliers of primary packaging materials to demonstrate that their ISO 9001-based quality management system addresses GMP-related expectations. This includes controls for contamination prevention, traceability, change control, deviation handling, CAPA, validation and supplier management.

Increasing Audit and Documentation Demands from Pharmaceutical Customers

Pharmaceutical customers are required to qualify and monitor their suppliers. For suppliers of primary packaging materials, this often results in customer audits, quality agreements, documentation requests and ongoing performance reviews.

ISO 15378 certification can support these supplier qualification and monitoring activities by providing independent evidence of a controlled quality management system. It can help create a common baseline for discussions with pharmaceutical customers, particularly where change control, deviation handling, CAPA, traceability and contamination prevention are relevant.

Regulatory and Market Drivers in Pharmaceutical Quality

Pharmaceutical manufacturers operate in a highly regulated environment and must demonstrate control over the quality of materials used in medicinal products. Primary packaging materials are part of this control strategy because they can affect product quality, integrity and patient safety.

ISO 15378 certification can support pharmaceutical customers by providing structured evidence that the packaging supplier operates a quality management system with GMP-related controls. However, the certification should be understood as supporting evidence within the supply chain, not as a regulatory approval of the packaging material.

Core Requirements for ISO 15378

Clause 4 — Context of the Organization

The organization defines the internal and external issues relevant to its quality management system, including customer expectations, applicable regulatory drivers and the intended use of the primary packaging materials. The scope of the management system must clearly reflect the packaging materials, sites, processes and outsourced activities covered by certification.

In line with ISO 15378:2017/Amd 1:2024, the organization must also consider whether climate-related issues are relevant to its quality management system context and to the expectations of relevant interested parties

Clause 5 — Leadership

Top management is responsible for establishing and maintaining an effective quality management system. This includes clear accountability for quality, GMP-related controls, customer requirements, risk-based thinking and the prevention of contamination, mix-ups and uncontrolled changes.

Leadership commitment should be visible through defined responsibilities, effective escalation paths, quality objectives and regular review of quality performance.

Clause 6 — Planning

The organization plans actions to address risks and opportunities that may affect product quality, process control and customer requirements. For ISO 15378, this includes risks related to contamination, mix-ups, traceability gaps, uncontrolled process changes, supplier failures and insufficient validation.

Planned changes to the quality management system, processes, equipment, facilities or materials must be controlled to prevent unintended effects on primary packaging quality.

Clause 7 — Support

The organization must provide the resources, infrastructure, work environment and competence needed to manufacture and supply primary packaging materials under controlled conditions. Training, personnel qualification, hygiene rules, documented information and record control are particularly important.

Documents and records such as batch documentation, specifications, deviation records, change controls, validation evidence and release records must be controlled, retained and protected against unintended loss, alteration or misuse.

Clause 8 — Operation

Operational controls are central to ISO 15378. The organization must plan and control design, purchasing, production, release and delivery activities to ensure that primary packaging materials meet defined requirements.

This includes supplier qualification, material traceability, contamination prevention, environmental controls where applicable, equipment qualification, process validation, control of outsourced processes, handling of nonconforming outputs and documented release of finished packaging materials.

Clause 9 — Performance Evaluation

The organization must monitor, measure, analyse and evaluate the effectiveness of its quality management system. Relevant inputs include customer feedback, complaints, deviations, nonconformities, supplier performance, process trends, audit results and the status of corrective actions.

Internal audits and management reviews must be performed at planned intervals and must include GMP-related aspects relevant to primary packaging materials.

Clause 10 — Improvement

The organization must identify opportunities for improvement and take corrective action when nonconformities occur. Deviations, complaints, audit findings and process failures must be investigated, evaluated for impact and addressed through effective corrective actions.

CAPA processes should be systematic, risk-based and supported by documented evidence. The effectiveness of corrective actions must be reviewed to confirm that the root cause has been adequately addressed.

Target Groups and Application Areas for ISO 15378

ISO 15378 is intended for manufacturers and suppliers of primary packaging materials used for medicinal products. Typical scope includes glass ampoules, vials, and cartridges; rubber stoppers and seals; aluminium closures and tubes; plastic bottles, blister films, and laminates; and printed primary packaging. The standard applies regardless of organization size, from specialized regional manufacturers to global packaging groups.

Pharmaceutical packaging customers — generic, branded, and contract manufacturers — increasingly require ISO 15378 certification as part of supplier qualification. The standard provides the basis for evidence-based purchasing and supports informed decisions by procurement, quality, and regulatory functions within pharmaceutical organizations.

ISO 15378 is also applicable to organizations supplying primary packaging materials to manufacturers of veterinary medicinal products and to certain medical device manufacturers where the packaging material is in direct contact with a regulated product. Products used only as secondary or tertiary packaging, such as outer cartons, shippers or pallet wrapping, normally fall outside the intended scope of ISO 15378.Related Standards

Harmonized Structure and Relationship to ISO 9001

ISO 15378 applies the requirements of ISO 9001:2015 to primary packaging materials for medicinal products and adds GMP-related requirements.. It incorporates the full text of ISO 9001 and adds requirements that reflect Good Manufacturing Practice expectations. Organizations already certified to ISO 9001 can typically transition or extend their certification to ISO 15378 through a focused gap analysis and audit.

Differentiation from ISO 13485

ISO 13485 specifies requirements for a quality management system for medical device manufacturers. Although both standards apply within highly regulated healthcare contexts and share QMS concepts, they cover different product categories. Where a primary packaging material is part of a combination product or a medical device, organizations may need to consider both standards. The two are not substitutable: ISO 15378 is the appropriate reference for primary packaging for medicinal products.

Sector-Specific Applications of ISO 9001

Other sector-specific applications of ISO 9001 include IATF 16949 (automotive), ISO/TS 22163 (railway), and AS9100 (aerospace). These are conceptually parallel to ISO 15378 — adding industry-specific quality requirements on top of the ISO 9001 baseline — but apply to different industries and are not in a derivative relationship with ISO 15378.

Complementary GMP Frameworks

ISO 15378 references GMP principles but is not a substitute for compliance with regional GMP regulations (EU GMP, U.S. cGMP, PIC/S GMP). Pharmaceutical manufacturers and their packaging suppliers remain accountable for compliance with the applicable regional framework. ISO 15378 certification supports — but does not replace — that compliance.